UnitedHealth Group UNH reported better-than-expected second-quarter earnings on Tuesday.
The company reported adjusted EPS of $6.80, up from $6.14 a year ago, beating the consensus of $6.66, according to data from Benzinga Pro. UnitedHealth’s revenues increased nearly $6 billion (+6.4% Y/Y) to $98.86 billion, beating the consensus of $98.34 billion, led by expansion in people served domestically at Optum and UnitedHealthcare.
UnitedHealth expects a 2024 net profit of $15.95-$16.40 per share to reflect the classification to held for sale of its remaining South America operations, and the estimated Change Healthcare cyberattack impacts versus the prior estimate of $17.60-$18.20.
UnitedHealth shares gained 6.5% to close at $548.87 on Tuesday.
These analysts made changes to their price targets on UnitedHealth after the company released quarterly results.
- Morgan Stanley analyst Ricky Goldwasser maintained UnitedHealth with an Overweight rating and boosted the price target from $595 to $615.
- Baird analyst Michael Ha maintained the stock with an Outperform rating, while increasing the price target from $597 to $640.
- Truist Securities analyst David Macdonald maintained UnitedHealth with a Buy rating, while boosting the price target from $600 to $640.
- Jefferies analyst David Windley upgraded UnitedHealth from Hold to Buy and increased the price target from $481 to $647.
Read Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.